We are live on
!
Find out more
BCM
Brookmont Capital Management Portfolio holdings
AUM
$186M
1-Year Est. Return
10.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.33%
1 Year Est. Return
+10.11%
3 Year Est. Return
+36.63%
5 Year Est. Return
+48.26%
10 Year Est. Return
+211.29%
AUM
$170M
AUM Growth
+$4.25M
(+2.6%)
Cap. Flow
+$2.48M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
54.95%
Holding
58
New
3
Increased
36
Reduced
12
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eastman Chemical
EMN
|
+$2.65M |
| 2 |
Vanguard Real Estate ETF
VNQ
|
+$318K |
| 3 |
FFWM
First Foundation Inc
FFWM
|
+$187K |
| 4 |
Honeywell
HON
|
+$68K |
| 5 |
DuPont de Nemours
DD
|
+$67.8K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$1.29M |
| 2 |
UnitedHealth
UNH
|
+$209K |
| 3 |
NVO
Novo Nordisk
NVO
|
+$96.3K |
| 4 |
Wells Fargo
WFC
|
+$43.6K |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$25K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.25% |
| 2 | Financials | 13.49% |
| 3 | Healthcare | 9.09% |
| 4 | Technology | 8.99% |
| 5 | Industrials | 8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $213K | 0.13% |
2,600
| – | – |
|
52
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $210K | 0.12% |
4,207
+199
| +5% | +$10.3K |
|
|
FFWM
53
DELISTED
First Foundation Inc
FFWM
| $206K | 0.12% |
+7,835
| New | +$187K |
|
54
Apple
AAPL
$4.57T
| $205K | 0.12% |
1,449
-20
| -1% | -$2.94K |
|
55
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
| $204K | 0.12% |
2,279
| – | – |
|
56
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $202K | 0.12% |
420
| – | – |
|
|
57
Unilever
UL
$136B
| – | – |
-19,606
| Closed | -$1.29M |
|
|
58
UnitedHealth
UNH
$370B
| – | – |
-522
| Closed | -$209K |
|
Similar funds
CC
BGA
OBC
HC
WWM
RCM
BAM
SVBP
Brookmont Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Brookmont Capital Management held 58 positions worth $170M, up 2.6% from $165M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Brookmont Capital Management's Q3 2021 filing shows 3 new, 36 increased, 12 reduced and 2 closed positions. Its largest new stake was Eastman Chemical: 24,030 shares worth $2.42M. The largest sale was Unilever, an estimated $1.29M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- Brookmont Capital Management's largest Q3 2021 buy was Eastman Chemical: 24,030 shares worth $2.42M.
- Brookmont Capital Management added most to Honeywell in Q3 2021, an estimated $68K increase.
- Brookmont Capital Management's biggest Q3 2021 reduction was Novo Nordisk, cutting an estimated $96.3K.
- Brookmont Capital Management fully exited Unilever in Q3 2021, selling an estimated $1.29M.
- Brookmont Capital Management's ten largest holdings make up 55% of its $170M portfolio in Q3 2021.
- Brookmont Capital Management opened 3 new positions and closed 2 in Q3 2021.
- Brookmont Capital Management's portfolio value rose 2.6% quarter-over-quarter to $170M.
Based on Brookmont Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.